COMPLEX III AUGMENTS OXIDANTS DAMAGE IN ISCHEMIC AGED HEART

复合物 III 增强缺血性老年心脏的氧化剂损伤

基本信息

  • 批准号:
    6783212
  • 负责人:
  • 金额:
    $ 12.76万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-04-01 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

Myocardial injury is increased following ischemia and reperfusion in the aged heart. Aging decreases the rate of oxidative phosphorylation and the activity of complexes HI and IV of the electron transport chain in the 24 mo. Fischer 344 rat heart, compared to 6 mo. adult controls. The aging impairment is selective to the interfibrillar population of cardiac mitochondria 0FM) that reside among the myofibrils, whereas subsarcolemmal mitochondria (SSM), located beneath the plasma membrane, are unaltered. Complex III contains 11 peptide subunits, including three catalytic centers: cytochrome b, cytochrome c1, and the Rieske iron-sulfur protein (ISP). Aging modifies cytochrome b at the site of substrate oxidation, the Qo site, in IFM. The aging defect in complex III in IFM leads to an increased production of reactive oxygen species (ROS) in the baseline state. Mitochondrial damage occurs during ischemia in the adult and aged heart. Ischemia damages the ISP of complex III and decreases complex III activity in both populations of mitochondria in adult and aged hearts. In contrast to the adult heart, the aged heart sustains additional oxidative damage to both SSM and IFM during ischemia. Cardiolipin, a key inner mitochondrial membrane phospholipid, is modified only in the aged heart, generating a new molecular species of cardiolipin. Cytochrome c, located in proximity to cardiolipin, is modified, again, only in the aged heart. Cytochrome oxidase activity decreases following ischemia in the aged heart, and, unlike in the adult heart, activity cannot be restored following the addition of exogenous phospholipid. This observation in the aged heart indicates that ischemia led to persistent damage to a peptide subunit of cytochrome oxidase, rather than reversible damage to the inner membrane environment of the complex as in the adult heart. Thus, during ischemia, specific molecular targets in the electron transport chain, including cardiolipin, sustain oxidative damage only in the aged heart. Mitochondria are the major source of the ROS generated during myocardial ischemia. Complex III is the major site of ROS production within mitochondria in the adult heart The role of complex III in the oxidative damage sustained by the aged heart during ischemia is unknown. We found that limitation of electron flow into complex III during ischemia achieved by blockade of complex I with rotenone immediately prior to ischemia preserves the rate of oxidative phosphorylation through complexes III and IV in the aged heart. We propose that during ischemia complex III is a key mechanism of the enhanced oxidative damage observed in the aged heart, We hypothesize that ROS from complex III damage cytochrome oxidase in the aged heart. Oxidative damage during ischemia is accelerated in IFM by the aging defect present at Qo site of complex III. We hypothesize that damage to cytochrome oxidase leads in turn to oxidative modification of cytochrome c and cardiolipin. We hypothesize that following ischemic damage to aged heart mitochondria, ROS production and release is increased, setting the stage for oxidative damage during reperfusion. Enhanced ROS release from mitochondria, in turn, amplifies cardiac damage and dysfunction during reperfusion that can be decreased by reversibly limiting electron flow into complex III during ischemia.
老年心脏缺血再灌注后心肌损伤加重。与成年对照6个月相比,衰老降低了24个月Fischer 344大鼠心脏的氧化磷酸化速率和电子传递链HI和IV复合物的活性。衰老损伤对心肌线粒体纤维间细胞群具有选择性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edward J Lesnefsky其他文献

Edward J Lesnefsky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edward J Lesnefsky', 18)}}的其他基金

Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
二甲双胍治疗衰老缺血性损伤和再灌注损伤
  • 批准号:
    10846164
  • 财政年份:
    2021
  • 资助金额:
    $ 12.76万
  • 项目类别:
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
二甲双胍治疗衰老缺血性损伤和再灌注损伤
  • 批准号:
    10298194
  • 财政年份:
    2021
  • 资助金额:
    $ 12.76万
  • 项目类别:
Metformin Therapy for Ischemic Insult and Reperfusion Injury in Aging
二甲双胍治疗衰老缺血性损伤和再灌注损伤
  • 批准号:
    10475290
  • 财政年份:
    2021
  • 资助金额:
    $ 12.76万
  • 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
  • 批准号:
    8457978
  • 财政年份:
    2012
  • 资助金额:
    $ 12.76万
  • 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
  • 批准号:
    8795682
  • 财政年份:
    2012
  • 资助金额:
    $ 12.76万
  • 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
  • 批准号:
    8698292
  • 财政年份:
    2012
  • 资助金额:
    $ 12.76万
  • 项目类别:
Reduction of cardiac injury by targeting damaged mitochondria during reperfusion
通过针对再灌注期间受损的线粒体来减少心脏损伤
  • 批准号:
    8333547
  • 财政年份:
    2012
  • 资助金额:
    $ 12.76万
  • 项目类别:
Mitochondrial Dysfunction in the Aged Heart: Role of Endoplasmic Reticulum Stress
老年心脏线粒体功能障碍:内质网应激的作用
  • 批准号:
    10513314
  • 财政年份:
    2012
  • 资助金额:
    $ 12.76万
  • 项目类别:
Mitochondrial Dysfunction in the Aged Heart: Role of Endoplasmic Reticulum Stress
老年心脏线粒体功能障碍:内质网应激的作用
  • 批准号:
    10254899
  • 财政年份:
    2012
  • 资助金额:
    $ 12.76万
  • 项目类别:
Myocardial Infarction in the Aging Heart: Ischemia-Damaged Mitochondria, Reticulum Stress and the Transition to Heart Failure
衰老心脏中的心肌梗死:缺血损伤的线粒体、网状应激和向心力衰竭的转变
  • 批准号:
    9239811
  • 财政年份:
    2012
  • 资助金额:
    $ 12.76万
  • 项目类别:

相似国自然基金

HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
  • 批准号:
    82371603
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
  • 批准号:
    82371585
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
  • 批准号:
    82370743
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
  • 批准号:
    82370774
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
  • 批准号:
    32000511
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
  • 批准号:
    32000510
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
核膜蛋白调节人干细胞稳态和衰老的机制研究
  • 批准号:
    31900523
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
FTO在调节人干细胞稳态和衰老中的作用
  • 批准号:
    31900524
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
FGF-MAPK-PINK1介导线粒体自噬延缓人脂肪干细胞衰老
  • 批准号:
    31900522
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
316LN锻造控氮奥氏体不锈钢热老化与应力腐蚀开裂敏感性研究
  • 批准号:
    51071136
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
  • 批准号:
    10676358
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
    Collaborative R&D
Bilingualism as a cognitive reserve factor: the behavioral and neural underpinnings of cognitive control in bilingual patients with aphasia
双语作为认知储备因素:双语失语症患者认知控制的行为和神经基础
  • 批准号:
    10824767
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
    Operating Grants
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
  • 批准号:
    10748479
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 12.76万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了